Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)

Funding Opportunity ID: 299068
Opportunity Number: PAS-18-188
Opportunity Title: Advancing Research on Alzheimer’s Disease (AD) and Alzheimer’s-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
CFDA Number(s): 93.866
Eligible Applicants: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Agency Code: HHS-NIH11
Agency Name: Department of Health and Human Services
National Institutes of Health
Posted Date: Nov 28, 2017
Close Date: Sep 05, 2019
Last Updated Date: Nov 28, 2017
Award Ceiling: $0
Award Floor: $0
Estimated Total Program Funding: $5,000,000
Expected Number of Awards: 10
Description: This Funding Opportunity Announcement (FOA) encourages applications to NIA’s Small Business Technology Transfer Research (STTR)program to conduct research leading to the development of innovative products and/or services that may advance progress in preventing and treating Alzheimer’s disease (AD) and Alzheimer’s-disease-related dementias (ADRD) and/or caring for and treating AD/ADRD patients.
Version: 1

Powered by WPeMatico